12:23 EDT Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols receive FDA clearance of IND application for Phase 1 trial of GIGA-2339
- Grifols restates financials for first half of 2024 due to incorrect accounting
- Grifols price target raised to EUR 15.45 from EUR 14.85 at Berenberg
- Grifols receives FDA approval for expanded XEMBIFY label
- Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients